Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of trimetazidine dihydrochloride prolonged-release 80 mg capsules under fasting conditions in healthy Thai volunteers
TCTR20230706005Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax at 36 hours, AUC0-t at 36 hours and 1 more. Started Jul 2023; status: completed.
Beyond the preview
Go deeper on TCTR20230706005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230706005.